TI
BIOTW

Telemetry Investments’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Telemetry Investments’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$10K Hold
153,694
– – 0.02% 114
2022
Q3 		$9K Hold
153,694
– – 0.01% 146
2022
Q2 		$6K Hold
153,694
– – 0.01% 170
2022
Q1 		$36K Buy
153,694
+15,000
+11% +$4.78K 0.06% 130
2021
Q4 		$90K Buy
138,694
+38,669
+39% +$26.8K 0.12% 130
2021
Q3 		$66K Buy
100,025
+15,025
+18% +$11.2K 0.09% 142
2021
Q2 		$73K Buy
+85,000
New +$59.1K 0.1% 117

Other funds holding BIOTW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return

Telemetry Investments's BIOTW Position: Q4 2022 in Review

Telemetry Investments held its Biotech Acquisition Company Warrant (BIOTW) position steady in Q4 2022 at 153,694 shares worth $10K. The position accounts for 0.02% of the portfolio, ranked #114.

Telemetry Investments first reported a position in BIOTW in Q2 2021 and has held it in 7 quarters since. The position peaked at $90K in Q4 2021. 48 funds tracked by Wall St. Rank hold BIOTW as of Q4 2022.

  • Telemetry Investments held 153,694 shares of Biotech Acquisition Company Warrant worth $10K as of Q4 2022.
  • Telemetry Investments left its Biotech Acquisition Company Warrant share count unchanged in Q4 2022.
  • Biotech Acquisition Company Warrant made up 0.02% of Telemetry Investments's portfolio in Q4 2022, its #114 holding.
  • Telemetry Investments first reported a position in Biotech Acquisition Company Warrant in Q2 2021 and has held it in 7 quarters since.
  • Telemetry Investments's Biotech Acquisition Company Warrant position peaked at $90K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.